SCHEMBL5774219

SCHEMBL5774219

c1ccc(-c2cc3nccc(N4CCCCC4)c3[nH]2)nc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 9/20 0.61
ROCK2 O75116 2/20 0.50
ROCK1 Q13464 2/20 0.50
CDC42BPB Q9Y5S2 2/20 0.50
METAP1 P53582 2/20 0.50
CCNB2 O95067 1/20 0.49
CDK1 P06493 1/20 0.49
CCNB1 P14635 1/20 0.49
GSK3B P49841 1/20 0.49
CDK5 Q00535 1/20 0.49
CDK5R1 Q15078 1/20 0.49
CCNB3 Q8WWL7 1/20 0.49
CHKA P35790 1/20 0.42
CNR2 P34972 1/20 0.42
LMNA P02545 1/20 0.41
TSHR P16473 1/20 0.41
MAPK1 P28482 1/20 0.41
RAB9A P51151 1/20 0.41
KMT2A Q03164 1/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5771574 0.84 NPY5R (0.65) NPY5R
Hydrochloric Acid SCHEMBL5776809 0.83 NPY5R (0.64) NPY5R
SCHEMBL5775524 0.81 NPY5R (0.71) NPY5RMETAP1CCNB2CDK1CCNB1
Hydrochloric Acid SCHEMBL5775692 0.79 NPY5R (0.68) NPY5RMETAP1CCNB2CDK1CCNB1
SCHEMBL5777964 0.77 NPY5R (0.57) NPY5RROCK2ROCK1CDC42BPBCCNB2
SCHEMBL5773072 0.77 CCNB2 (0.52) NPY5RCCNB2CDK1CCNB1CCNB3
SCHEMBL5774091 0.76 NPY5R (1.00) NPY5R
SCHEMBL5776649 0.75 NPY5R (0.40) NPY5RROCK2ROCK1CDC42BPBCHKA
Hydrochloric Acid SCHEMBL5776805 0.74 PSMB5 (0.41) NPY5RROCK2ROCK1CDC42BPBCHKA
Hydrochloric Acid SCHEMBL5775904 0.74 NPY5R (0.96) NPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP claimed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US claimed
EP-1054887-B1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC (US) 2006-04-12 EP disclosed
US-6583154-B1 Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines AMGEN INC. 2003-06-24 US disclosed
US-6187777-B1 PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS AMGEN INC. 2001-02-13 US disclosed
EP-1054887-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS Amgen Inc. (US) 2000-11-29 EP disclosed
WO-1999040091-A1 BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS AMGEN INC. (US) 1999-08-12 WO disclosed